Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany

BACKGROUND: Overuse of short-acting beta-2 agonists (SABA), which do not treat the underlying inflammation of asthma, is linked to poor clinical outcomes such as increased exacerbation risk. This study, as part of the SABINA program, estimated the prevalence of SABA overuse and associated variables...

Descripción completa

Detalles Bibliográficos
Autores principales: Worth, Heinrich, Criée, Carl-Peter, Vogelmeier, Claus F., Kardos, Peter, Becker, Eva-Maria, Kostev, Karel, Mokros, Ingo, Schneider, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051057/
https://www.ncbi.nlm.nih.gov/pubmed/33863317
http://dx.doi.org/10.1186/s12931-021-01701-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051057/
https://www.ncbi.nlm.nih.gov/pubmed/33863317
http://dx.doi.org/10.1186/s12931-021-01701-3

Ejemplares similares